BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Deals

  GenTech Scientific and Conquer Scientific Combine to Become Global Leader in the Used and Refurbished Scientific Instruments Market

  Purity Scientific LLC announced that it has acquired Conquer Scientific.

  February 1, 2022

   · 

  3 min read
• Pharm Country

  First Patient Enrolled in the PROCYSS Multicenter Randomized Controlled Trial Evaluating CytoSorb® to Restore Hemodynamic Stability in Patients with Refractory Septic Shock

  CytoSorbents Corporation announced today that the first patient has been enrolled in the PROCYSS trial in Germany by Prof. Dr. Stefan Kluge, Director, Department of Intensive Care Medicine at the University Hospital Hamburg Eppendorf and lead investigator of the PROCYSS trial.

  February 1, 2022

   · 

  8 min read
• Business

  ImmuneID Appoints Jeremiah Degenhardt, Ph.D., as SVP Computational Biology

  ImmuneID today announced the appointment of Jeremiah Degenhardt, Ph.D., as Senior Vice President, Computational Biology.

  February 1, 2022

   · 

  3 min read
• Business

  Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call and Webcast on February 8, 2022

  Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that it will report its fourth quarter and full year 2021 financial results on Tuesday, February 8, 2022.

  February 1, 2022

   · 

  1 min read
• Business

  AVROBIO Announces the Appointment of Sean O’Bryan as Chief Regulatory Officer

  AVROBIO, Inc. today announced the appointment of Sean O’Bryan as chief regulatory officer.

  February 1, 2022

   · 

  6 min read
• Business

  Catalent, Inc. Reports Second Quarter Fiscal 2022 Results

  Catalent, Inc. today announced financial results for the second quarter of fiscal 2022, which ended December 31, 2021.

  February 1, 2022

   · 

  25 min read
• Business

  Glaukos Corporation to Release Fourth Quarter and Full Year 2021 Financial Results after Market Close on February 22

  Glaukos Corporation plans to release fourth quarter and full year 2021 financial results after the market close on Tuesday, February 22, 2022.

  February 1, 2022

   · 

  1 min read
• Business

  Enanta Pharmaceuticals to Host Conference Call on February 8 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2021

  Enanta Pharmaceuticals, Inc. today announced that it plans to report its financial results for its fiscal first quarter ended December 31, 2021 after the U.S. market closes on February 8, 2022.

  February 1, 2022

   · 

  2 min read
• Biotech Bay

  ZAP Surgical Announces Installation of its Pioneering Radiosurgery Platform at Japanese Bullet Train Station

  ZAP Surgical Systems, Inc. today announced installation of its first ZAP-X® Gyroscopic Radiosurgery® platform in Japan.

  February 1, 2022

   · 

  5 min read
• Business

  Drs. Margaret Dugan and Alessandro Riva Appointed to BeiGene Board of Directors

  BeiGene today announced the appointment of Margaret Dugan, M.D., and Alessandro Riva, M.D., to its Board of Directors.

  February 1, 2022

   · 

  6 min read